Evidence map›Paper›PMID 33235398›Full record

SynthesisTropical biomedicine2020

Evaluation of the malaria elimination policy in Brazil: a systematic review and epidemiological analysis study.

J O Melo, M A O Padilha, R T A Barbosa, W J Alonso, A Y Vittor, G Z Laporta

Open access · greenAbstract readSystematic Review
In one paragraph

Synthesis in Tropical biomedicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

J O MeloSetor de Pos-graduaçao, Pesquisa e Inovação, Centro Universitârio Saûde ABC, Fundação do ABC, Santo André, SP, Brazil.
M A O PadilhaSetor de Pos-graduaçao, Pesquisa e Inovação, Centro Universitârio Saûde ABC, Fundação do ABC, Santo André, SP, Brazil.
R T A BarbosaSetor de Pos-graduaçao, Pesquisa e Inovação, Centro Universitârio Saûde ABC, Fundação do ABC, Santo André, SP, Brazil.
W J AlonsoCartagena, Spain.
A Y VittorDepartment of Medicine and Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA.
G Z LaportaSetor de Pos-graduaçao, Pesquisa e Inovação, Centro Universitârio Saûde ABC, Fundação do ABC, Santo André, SP, Brazil.
University of Florida · US

Funding

Heterologous immunity and host susceptibility to emerging alphaviral infectionsK08AI116980 · NIAID · UNIVERSITY OF FLORIDA · PI VITTOR, AMY YOMIKO · 2016 to 2020
$888k
NIAID NIH HHS K08 AI116980
6 · The paper itself

Abstract

After a centenary fight against malaria, Brazil has seen an opportunity for change with the proposal of the malaria elimination policy set by the Brazilian government, in line with malaria elimination policies in other Latin American countries. Brazilian malaria experts regard eliminating malaria by 2030 to be within reach. Herein we evaluated the likelihood that malaria elimination can be accomplished in Brazil through systematic review of the literature on malaria elimination in Brazil and epidemiological analysis. Fifty-two articles referring to malaria eradication/elimination in Brazil were analyzed to identify challenges and technological breakthroughs for controlling malaria. Monthly deaths (1979-2016) and monthly severe malaria cases (1998-2018) were analyzed according to age groups, geographic region and parasite species. As a result, we observed that the declining malaria burden was mostly attributable to a decline in

Indexed as

AntimalarialsBrazilDisease EradicationHumansMalariaMalaria, FalciparumMalaria, VivaxPolicyAntimalarials

Identifiers

PMID33235398
PMCPMC7682744
OpenAlexW3110644175

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.